<qa>  What is the dose-limiting toxicity of MLN2704?This is a Phase 1 open-label dose-escalating trial designed to determine the dose-limiting toxicity DLT, maximum tolerated dose MTD and pharmacokinetics of a single dose of MLN2704 in subjects with metastatic androgen-independent prostate cancer. 